Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma.
about
Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma.Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compoundThe efficacy and adverse event profile of dexamethasone, melphalan, actinomycin D, and cytosine arabinoside (DMAC) chemotherapy in relapsed canine lymphomaEvaluation of the risks of chemotherapy in dogs with thrombocytopenia.Comparison of a CHOP-LAsp-based protocol with and without maintenance for canine multicentric lymphoma.Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma.Thymidine kinase assay in canine lymphoma.Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation6-Thioguanine and zebularine down-regulate DNMT1 and globally demethylate canine malignant lymphoid cells.Profiling of serum metabolites in canine lymphoma using gas chromatography mass spectrometryCentral nervous system relapses in 3 dogs with B-cell lymphoma.Doxorubicin and cyclophosphamide for the treatment of canine lymphoma: a randomized, placebo-controlled study.Hyperferritinemia is associated with short survival time in dogs with multicentric lymphomaManaging the canine lymphosarcoma patient in general practiceHypoxia inducible factor 1α expression and effects of its inhibitors in canine lymphomaMolecular profiling reveals prognostically significant subtypes of canine lymphoma.Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma.Breed-predispositions to cancer in pedigree dogs.Autologous peripheral blood hematopoietic cell transplantation in dogs with T-cell lymphoma.Predictive value of ex vivo biodynamic imaging in determining response to chemotherapy in dogs with spontaneous non-Hodgkin's lymphomas: a preliminary study.Mutation of p53 Gene and Its Correlation with the Clinical Outcome in Dogs with Lymphoma.Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applicationsDevelopment of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential.Treatment of feline intermediate- to high-grade lymphoma with a modified university of Wisconsin-Madison protocol: 119 cases (2004-2012).Clinical and histopathological evaluation of 16 dogs with T-zone lymphoma.The dog as a possible animal model for human non-Hodgkin lymphoma: a review.A novel canine B-cell leukaemia cell line. Establishment, characterisation and sensitivity to chemotherapeutics.Canine lymphoma: a review.Anti-tumor effects of perphenazine on canine lymphoma.Conformity and controversies in the diagnosis, staging and follow-up evaluation of canine nodal lymphoma: a systematic review of the last 15 years of published literature.Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.Investigation of the cytotoxic effect of flavopiridol in canine lymphoma cell lines.Treatment of feline lymphoma using a 12-week, maintenance-free combination chemotherapy protocol in 26 cats.Criteria for designation of clinical substage in canine lymphoma: a survey of veterinary oncologists.Increase in minimal residual disease in peripheral blood before clinical relapse in dogs with lymphoma that achieved complete remission after chemotherapy.Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma.Expression of O(6)-methylguanine-DNA methyltransferase causes lomustine resistance in canine lymphoma cells.Detection of circulating tumor cells using GeneScan analysis for antigen receptor gene rearrangements in canine lymphoma patients.Asparaginase-associated pancreatitis in a dog.
P2860
Q24534920-36AECC70-E5BC-4866-B76B-DDCCAE4B8FE5Q27027137-F0AA995A-0184-4B16-B9D4-F1500023583BQ28292596-B82425CE-E8AE-496E-AE07-E7D8B92AF4DAQ33413087-4A654EC7-78E5-4357-8FC8-E8E9386834D3Q33421905-685B9495-302F-42E1-9922-AC5E6B46AEB9Q33438551-93F5BFE0-FF3C-4486-BECC-6FDF48C37BC9Q33698548-F5494988-56A8-4A8E-AF3C-3EBECD49BF23Q34246274-517058BE-A120-4BCE-9E17-5EF7C5C63C2CQ34568337-39BA5A5C-F0E1-4866-9541-9D29A90E2FD2Q34748281-BDCAEFDE-B23B-4392-9FD6-C7ADC7A869CCQ34749776-79F1D86E-FE16-425B-83CA-D9B8629ABAAEQ35057461-E82431B3-CF6D-43AD-9BF1-D1ACE0FA1A60Q35086217-5821D1BD-4A53-46BB-B791-D39849A40B7CQ35924142-9B391CD6-69A6-4645-B90E-32F78CA45174Q35944329-8FFB4857-F0AF-4DC3-BB15-DA76B73878CEQ36341443-977CBD30-7570-4B2A-87FB-E04ECB8D9A31Q36381346-74B35FC9-89A4-4093-A8A6-1DFF2D576F92Q36575008-6ACA7ECF-CCB9-4BD7-96C4-EB56503CC75EQ36857180-98602865-2216-47A5-A701-A56BA6160308Q36873348-F4622B26-AD08-440A-AC25-470894CF4F03Q36972380-08CD9453-505D-48C1-BA4A-E4BCBC74F7D2Q37020362-E6F908C5-A2E9-4E85-962B-7351B4F3F6C3Q37196999-19385E35-07E0-4B8C-9FEC-25871166637BQ37212371-A7F68A1E-63AB-4891-A404-E4AB845B00D1Q37234338-7AECA96C-9864-41B5-850D-DD03AF77C498Q37317882-A6269E26-5363-4118-94C3-CBDE26E180FDQ38016826-5D32CF73-0CC8-4B99-81BE-E9834A2D0B9EQ38752822-1A859B37-195B-44ED-8C17-FFB94904B8F1Q38765145-A694FFB8-B46F-472A-B4CB-98B98DED10B0Q38773022-002B55AB-844E-4AD3-8E98-B71E609573CDQ38842189-5068DCE7-5CC1-4679-B50A-7B5A0FAF5C65Q38906083-6DAEA5AB-1D89-417A-9414-F28C22C97C85Q38916209-0E676052-8094-47B3-A28F-946443869813Q39248797-47B41FF1-B3F3-4AD5-8044-0BC513572FACQ39504944-44A9DE0F-BB61-4E22-BD15-2AB042FF41B2Q39593967-1EAE1E52-1771-4A53-9D32-D5AD08304B39Q39622633-D1B59558-CCE5-4A78-860D-5773F6231185Q41146582-93184DAE-6808-464F-8E96-57B7876CD354Q41771773-45CB8279-8EB4-477B-AC3F-37B008D4F8BFQ42019280-B3C67C4C-3D2C-4104-BD09-E4F122D41FC8
P2860
Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Evaluation of a 6-month chemot ...... herapy for dogs with lymphoma.
@ast
Evaluation of a 6-month chemot ...... herapy for dogs with lymphoma.
@en
type
label
Evaluation of a 6-month chemot ...... herapy for dogs with lymphoma.
@ast
Evaluation of a 6-month chemot ...... herapy for dogs with lymphoma.
@en
prefLabel
Evaluation of a 6-month chemot ...... herapy for dogs with lymphoma.
@ast
Evaluation of a 6-month chemot ...... herapy for dogs with lymphoma.
@en
P2093
P1476
Evaluation of a 6-month chemot ...... herapy for dogs with lymphoma.
@en
P2093
David M Vail
Douglas H Thamm
Laura D Garrett
Robert Dudley
Ruthanne Chun
P304
P356
10.1111/J.1939-1676.2002.TB02411.X
P577
2002-11-01T00:00:00Z